<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0000621"><a href="http://purl.obolibrary.org/obo/MONDO_0000621">MONDO:0000621</a></h3>
<p><strong>Label:</strong> immune system cancer</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019438">MONDO:0019438</a> (AL amyloidosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019111">MONDO:0019111</a> (familial thrombocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0007926">MONDO:0007926</a> (Waldenstrom macroglobulinemia), <a href="http://purl.obolibrary.org/obo/MONDO_0005029">MONDO:0005029</a> (essential thrombocythemia), <a href="http://purl.obolibrary.org/obo/MONDO_0005587">MONDO:0005587</a> (non-Hodgkins lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0007243">MONDO:0007243</a> (Burkitts lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0011996">MONDO:0011996</a> (chronic myelogenous leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0015759">MONDO:0015759</a> (b-cell non-Hodgkin lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0018908">MONDO:0018908</a> (non-Hodgkin lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0005062">MONDO:0005062</a> (lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0018905">MONDO:0018905</a> (diffuse large b-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0018906">MONDO:0018906</a> (follicular lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0011118">MONDO:0011118</a> (acute myeloid leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0015758">MONDO:0015758</a> (primary cutaneous T-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0015820">MONDO:0015820</a> (primary cutaneous b-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0018897">MONDO:0018897</a> (primary cutaneous CD30+ T-cell lymphoproliferative disease), <a href="http://purl.obolibrary.org/obo/MONDO_0018898">MONDO:0018898</a> (primary cutaneous lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0004948">MONDO:0004948</a> (chronic lymphocytic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0020331">MONDO:0020331</a> (indolent systemic mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0009348">MONDO:0009348</a> (classic Hodgkin lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0007896">MONDO:0007896</a> (acute monocytic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0017604">MONDO:0017604</a> (marginal zone lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0017207">MONDO:0017207</a> (primary organ-specific lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0015821">MONDO:0015821</a> (mycosis fungoides and variants), <a href="http://purl.obolibrary.org/obo/MONDO_0013794">MONDO:0013794</a> (thrombocythemia 3), <a href="http://purl.obolibrary.org/obo/MONDO_0011173">MONDO:0011173</a> (thrombocythemia 2), <a href="http://purl.obolibrary.org/obo/MONDO_0009692">MONDO:0009692</a> (primary myelofibrosis), <a href="http://purl.obolibrary.org/obo/MONDO_0009693">MONDO:0009693</a> (multiple myeloma), <a href="http://purl.obolibrary.org/obo/MONDO_0017595">MONDO:0017595</a> (aggressive b-cell non-Hodgkin lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0019454">MONDO:0019454</a> (refractory anemia with excess blasts), <a href="http://purl.obolibrary.org/obo/MONDO_0019452">MONDO:0019452</a> (chronic myeloproliferative disease, unclassifiable), <a href="http://purl.obolibrary.org/obo/MONDO_0015691">MONDO:0015691</a> (hypereosinophilic syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0017594">MONDO:0017594</a> (indolent b-cell non-Hodgkin lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0000432">MONDO:0000432</a> (lymphoplasmacytic lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0020325">MONDO:0020325</a> (anaplastic large cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0004952">MONDO:0004952</a> (Hodgkins lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0006456">MONDO:0006456</a> (thymoma (disease)), <a href="http://purl.obolibrary.org/obo/MONDO_0015819">MONDO:0015819</a> (indolent primary cutaneous b-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0015818">MONDO:0015818</a> (aggressive primary cutaneous b-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0006451">MONDO:0006451</a> (thymic carcinoma), <a href="http://purl.obolibrary.org/obo/MONDO_0015817">MONDO:0015817</a> (aggressive primary cutaneous T-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0015816">MONDO:0015816</a> (indolent primary cutaneous T-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0017834">MONDO:0017834</a> (secondary hypereosinophilic syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0015760">MONDO:0015760</a> (T-cell non-Hodgkin lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0008554">MONDO:0008554</a> (thrombocythemia 1), <a href="http://purl.obolibrary.org/obo/MONDO_0020311">MONDO:0020311</a> (chronic myelomonocytic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0020312">MONDO:0020312</a> (atypical chronic myeloid leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0005615">MONDO:0005615</a> (plasmacytoma), <a href="http://purl.obolibrary.org/obo/MONDO_0020511">MONDO:0020511</a> (precursor b-cell acute lymphoblastic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0004967">MONDO:0004967</a> (acute lymphoblastic leukemia (disease)), <a href="http://purl.obolibrary.org/obo/MONDO_0004963">MONDO:0004963</a> (T-cell acute lymphoblastic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0020076">MONDO:0020076</a> (myeloproliferative neoplasm), <a href="http://purl.obolibrary.org/obo/MONDO_0005171">MONDO:0005171</a> (chronic myeloproliferative disorder), <a href="http://purl.obolibrary.org/obo/MONDO_0013667">MONDO:0013667</a> (myelodysplastic syndrome),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_178548">Orphanet:178548</a>, <a href="http://www.orpha.net/ORDO/Orphanet_86839">Orphanet:86839</a>, <a href="http://www.orpha.net/ORDO/Orphanet_300846">Orphanet:300846</a>, <a href="http://www.orpha.net/ORDO/Orphanet_33226">Orphanet:33226</a>, <a href="http://purl.obolibrary.org/obo/OMIM_151380">OMIM:151380</a>, <a href="http://www.orpha.net/ORDO/Orphanet_300842">Orphanet:300842</a>, <a href="http://purl.obolibrary.org/obo/OMIM_153600">OMIM:153600</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613065">OMIM:613065</a>, <a href="http://www.orpha.net/ORDO/Orphanet_86830">Orphanet:86830</a>, <a href="http://purl.obolibrary.org/obo/OMIM_247640">OMIM:247640</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613067">OMIM:613067</a>, <a href="http://www.orpha.net/ORDO/Orphanet_67038">Orphanet:67038</a>, <a href="http://www.orpha.net/ORDO/Orphanet_3318">Orphanet:3318</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613024">OMIM:613024</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610430">OMIM:610430</a>, <a href="http://www.orpha.net/ORDO/Orphanet_519">Orphanet:519</a>, <a href="http://www.orpha.net/ORDO/Orphanet_171901">Orphanet:171901</a>, <a href="http://www.orpha.net/ORDO/Orphanet_514">Orphanet:514</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99867">Orphanet:99867</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99868">Orphanet:99868</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609630">OMIM:609630</a>, <a href="http://purl.obolibrary.org/obo/OMIM_254500">OMIM:254500</a>, <a href="http://purl.obolibrary.org/obo/OMIM_274230">OMIM:274230</a>, <a href="http://www.orpha.net/ORDO/Orphanet_71493">Orphanet:71493</a>, <a href="http://www.orpha.net/ORDO/Orphanet_513">Orphanet:513</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99860">Orphanet:99860</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178557">Orphanet:178557</a>, <a href="http://purl.obolibrary.org/obo/OMIM_186770">OMIM:186770</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300331">OMIM:300331</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98293">Orphanet:98293</a>, <a href="http://purl.obolibrary.org/obo/OMIM_605027">OMIM:605027</a>, <a href="http://purl.obolibrary.org/obo/OMIM_601626">OMIM:601626</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178551">Orphanet:178551</a>, <a href="http://www.orpha.net/ORDO/Orphanet_391">Orphanet:391</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178554">Orphanet:178554</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614286">OMIM:614286</a>, <a href="http://purl.obolibrary.org/obo/OMIM_113970">OMIM:113970</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614521">OMIM:614521</a>, <a href="http://purl.obolibrary.org/obo/OMIM_254450">OMIM:254450</a>, <a href="http://www.orpha.net/ORDO/Orphanet_171915">Orphanet:171915</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98848">Orphanet:98848</a>, <a href="http://www.orpha.net/ORDO/Orphanet_168956">Orphanet:168956</a>, <a href="http://www.orpha.net/ORDO/Orphanet_547">Orphanet:547</a>, <a href="http://www.orpha.net/ORDO/Orphanet_824">Orphanet:824</a>, <a href="http://purl.obolibrary.org/obo/OMIM_400021">OMIM:400021</a>, <a href="http://www.orpha.net/ORDO/Orphanet_223735">Orphanet:223735</a>, <a href="http://www.orpha.net/ORDO/Orphanet_544">Orphanet:544</a>, <a href="http://www.orpha.net/ORDO/Orphanet_543">Orphanet:543</a>, <a href="http://www.orpha.net/ORDO/Orphanet_171918">Orphanet:171918</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98841">Orphanet:98841</a>, <a href="http://www.orpha.net/ORDO/Orphanet_314962">Orphanet:314962</a>, <a href="http://purl.obolibrary.org/obo/OMIM_236000">OMIM:236000</a>, <a href="http://www.orpha.net/ORDO/Orphanet_545">Orphanet:545</a>, <a href="http://purl.obolibrary.org/obo/OMIM_187950">OMIM:187950</a>, <a href="http://www.orpha.net/ORDO/Orphanet_542">Orphanet:542</a>, <a href="http://www.orpha.net/ORDO/Orphanet_541">Orphanet:541</a>, <a href="http://www.orpha.net/ORDO/Orphanet_52688">Orphanet:52688</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300221">OMIM:300221</a>, <a href="http://purl.obolibrary.org/obo/OMIM_601977">OMIM:601977</a>, <a href="http://www.orpha.net/ORDO/Orphanet_86855">Orphanet:86855</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178566">Orphanet:178566</a>, <a href="http://www.orpha.net/ORDO/Orphanet_85443">Orphanet:85443</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178563">Orphanet:178563</a>, <a href="http://purl.obolibrary.org/obo/OMIM_151400">OMIM:151400</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98836">Orphanet:98836</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615545">OMIM:615545</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612558">OMIM:612558</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612557">OMIM:612557</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612559">OMIM:612559</a>, <a href="http://purl.obolibrary.org/obo/OMIM_109543">OMIM:109543</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98274">Orphanet:98274</a>, <a href="http://www.orpha.net/ORDO/Orphanet_300912">Orphanet:300912</a>, <a href="http://www.orpha.net/ORDO/Orphanet_29073">Orphanet:29073</a>, <a href="http://purl.obolibrary.org/obo/OMIM_131440">OMIM:131440</a>, <a href="http://www.orpha.net/ORDO/Orphanet_279911">Orphanet:279911</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98823">Orphanet:98823</a>, <a href="http://www.orpha.net/ORDO/Orphanet_314701">Orphanet:314701</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98824">Orphanet:98824</a>, <a href="http://purl.obolibrary.org/obo/OMIM_608232">OMIM:608232</a>, <a href="http://www.orpha.net/ORDO/Orphanet_521">Orphanet:521</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011121">HP:0011121</a> (Abnormality of skin morphology))) 52.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000271">HP:0000271</a> (Abnormality of the face))) 51.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000234">HP:0000234</a> (Abnormality of the head))) 51.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000152">HP:0000152</a> (Abnormality of head or neck))) 51.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011024">HP:0011024</a> (Abnormality of the gastrointestinal tract))) 49.99%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology))) 49.51%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001626">HP:0001626</a> (Abnormality of the cardiovascular system))) 49.35%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011354">HP:0011354</a> (Generalized abnormality of skin))) 48.63%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002597">HP:0002597</a> (Abnormality of the vasculature))) 48.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011842">HP:0011842</a> (Abnormality of skeletal morphology))) 48.07%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000924">HP:0000924</a> (Abnormality of the skeletal system))) 47.42%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012252">HP:0012252</a> (Abnormal respiratory system morphology))) 46.55%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) 46.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000026">HP:0000026</a> (Male hypogonadism))) 46.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000024">HP:0000024</a> (Prostatitis))) 46.30%</li>
</ul>
</body>
</html>
